Autumn Lake Healthcare At Chesapeake Woods | |
525 Glenburn Avenue, Cambridge, Maryland 21613 | |
(410) 221-1400 | |
Name | Autumn Lake Healthcare At Chesapeake Woods |
---|---|
Location | 525 Glenburn Avenue, Cambridge, Maryland |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 98 |
Occupancy Rate | 85% |
Medicare ID (CCN) | 215221 |
Legal Business Name | Legal Business Name Not Available |
Ownership Type | For Profit - Corporation |
NPI Number | 1164604625 |
Organization Name | 525 GLENBURN AVENUE OPERATIONS LLC |
Doing Business As | CHESAPEAKE WOODS CENTER |
Address | 525 Glenburn Ave, Cambridge, MD 21613 |
Phone Number | 410-221-1400 |
News Archive
Synovis Life Technologies, Inc., today reported financial results for the first fiscal quarter ended Jan. 31, 2010.
While immediate postexposure treatment for suspected HIV is critical, pre-exposure preventive treatment is a newer method that may be effective for people in high-risk groups, states a review of evidence published in CMAJ (Canadian Medical Association Journal).
Hodgkin lymphoma survivors have more severe coronary artery disease 20 years after chest irradiation, according to research presented today at ICNC 2017.
A new international study of children with a severe form of acute lymphoblastic leukemia (ALL) shows that certain chromosome losses can signal an especially poor response to therapy, but that other chromosome abnormalities have no effect on treatment survival.
A new, recently licensed medical device developed by University at Buffalo researchers would introduce into intensive care settings the powerful and effective method of anesthetizing patients that works so well in the operating room.
› Verified 6 days ago
NPI Number | 1528013802 |
Organization Name | MERIDIAN HEALTHCARE, INC |
Doing Business As | CHESAPEAKE WOODS CENTER |
Address | 525 Glenburn Ave, Cambridge, MD 21613 |
Phone Number | 410-221-1400 |
News Archive
Synovis Life Technologies, Inc., today reported financial results for the first fiscal quarter ended Jan. 31, 2010.
While immediate postexposure treatment for suspected HIV is critical, pre-exposure preventive treatment is a newer method that may be effective for people in high-risk groups, states a review of evidence published in CMAJ (Canadian Medical Association Journal).
Hodgkin lymphoma survivors have more severe coronary artery disease 20 years after chest irradiation, according to research presented today at ICNC 2017.
A new international study of children with a severe form of acute lymphoblastic leukemia (ALL) shows that certain chromosome losses can signal an especially poor response to therapy, but that other chromosome abnormalities have no effect on treatment survival.
A new, recently licensed medical device developed by University at Buffalo researchers would introduce into intensive care settings the powerful and effective method of anesthetizing patients that works so well in the operating room.
› Verified 6 days ago
NPI Number | 1639452527 |
Organization Name | GENESIS HEALTHCARE |
Address | 525 Glenburn Ave, Cambridge, MD 21613 |
Phone Number | 410-221-1400 |
News Archive
Synovis Life Technologies, Inc., today reported financial results for the first fiscal quarter ended Jan. 31, 2010.
While immediate postexposure treatment for suspected HIV is critical, pre-exposure preventive treatment is a newer method that may be effective for people in high-risk groups, states a review of evidence published in CMAJ (Canadian Medical Association Journal).
Hodgkin lymphoma survivors have more severe coronary artery disease 20 years after chest irradiation, according to research presented today at ICNC 2017.
A new international study of children with a severe form of acute lymphoblastic leukemia (ALL) shows that certain chromosome losses can signal an especially poor response to therapy, but that other chromosome abnormalities have no effect on treatment survival.
A new, recently licensed medical device developed by University at Buffalo researchers would introduce into intensive care settings the powerful and effective method of anesthetizing patients that works so well in the operating room.
› Verified 6 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Synovis Life Technologies, Inc., today reported financial results for the first fiscal quarter ended Jan. 31, 2010.
While immediate postexposure treatment for suspected HIV is critical, pre-exposure preventive treatment is a newer method that may be effective for people in high-risk groups, states a review of evidence published in CMAJ (Canadian Medical Association Journal).
Hodgkin lymphoma survivors have more severe coronary artery disease 20 years after chest irradiation, according to research presented today at ICNC 2017.
A new international study of children with a severe form of acute lymphoblastic leukemia (ALL) shows that certain chromosome losses can signal an especially poor response to therapy, but that other chromosome abnormalities have no effect on treatment survival.
A new, recently licensed medical device developed by University at Buffalo researchers would introduce into intensive care settings the powerful and effective method of anesthetizing patients that works so well in the operating room.
› Verified 6 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 21.68 | 14.46 |
Percentage of long-stay residents who lose too much weight | 5.35 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 54.43 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 2.67 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0.67 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 5.13 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.36 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 19.93 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 84.05 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 29.29 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 9.65 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 5.53 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.77 | 95.98 |
Percentage of short-stay residents who made improvements in function | 71.04 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 92.52 | 82.93 |
News Archive
Synovis Life Technologies, Inc., today reported financial results for the first fiscal quarter ended Jan. 31, 2010.
While immediate postexposure treatment for suspected HIV is critical, pre-exposure preventive treatment is a newer method that may be effective for people in high-risk groups, states a review of evidence published in CMAJ (Canadian Medical Association Journal).
Hodgkin lymphoma survivors have more severe coronary artery disease 20 years after chest irradiation, according to research presented today at ICNC 2017.
A new international study of children with a severe form of acute lymphoblastic leukemia (ALL) shows that certain chromosome losses can signal an especially poor response to therapy, but that other chromosome abnormalities have no effect on treatment survival.
A new, recently licensed medical device developed by University at Buffalo researchers would introduce into intensive care settings the powerful and effective method of anesthetizing patients that works so well in the operating room.
› Verified 6 days ago
Signature Healthcare At Mallard Bay Location: 520 Glenburn Avenue, Cambridge, Maryland 21613 Phone: (410) 228-9191 | |
Autumn Lake Healthcare At Chesapeake Woods Location: 525 Glenburn Avenue, Cambridge, Maryland 21613 Phone: (410) 221-1400 |